• Benign Prostatic Hyperplasia
  • Hormone Therapy
  • Genomic Testing
  • Next-Generation Imaging
  • UTUC
  • OAB and Incontinence
  • Genitourinary Cancers
  • Kidney Cancer
  • Men's Health
  • Pediatrics
  • Female Urology
  • Sexual Dysfunction
  • Kidney Stones
  • Urologic Surgery
  • Bladder Cancer
  • Benign Conditions
  • Prostate Cancer

Study backs increased PSA screening for younger African Americans


Study results presented during the 2021 ASCO Annual Meeting showed an association between increased prostate-specific antigen (PSA) screening and improved outcomes in younger African American patients.

In this video, lead study author Edmund M. Qiao, a medical student at the University of California San Diego, discusses how the results show that in younger African Americans, an increase in the frequency of PSA screening was linked to a nearly 25% reduction in prostate cancer–specific mortality and an approximately 40% lower risk of having metastatic disease at the time of a prostate cancer diagnosis. Based on their findings, the researchers recommend that younger African Americans begin having discussions early with their physicians regarding whether they need screening.

Related Videos
Michael S. Cookson, MD, MMHC, FACS, answers a question during a Zoom video interview
Related Content
© 2024 MJH Life Sciences

All rights reserved.